Sonoma Pharmaceuticals, Inc. (SNOA) DCF Valuation

Sonoma Pharmaceuticals, Inc. (SNOA) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Sonoma Pharmaceuticals, Inc. (SNOA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate the financial outlook of Sonoma Pharmaceuticals, Inc. (SNOA) like an expert! This (SNOA) DCF Calculator provides pre-filled financial data and offers full flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your predictions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 18.9 18.6 12.6 13.3 12.7 11.7 10.7 9.9 9.0 8.3
Revenue Growth, % 0 -1.62 -32.21 5.1 -4.05 -8.2 -8.2 -8.2 -8.2 -8.2
EBITDA -3.2 -3.2 -5.7 -4.4 -4.5 -3.5 -3.2 -2.9 -2.7 -2.5
EBITDA, % -16.98 -17.3 -45.15 -33.49 -35.53 -29.69 -29.69 -29.69 -29.69 -29.69
Depreciation .3 .2 .4 .3 .2 .2 .2 .2 .2 .2
Depreciation, % 1.65 1.22 3.24 2.25 1.38 1.95 1.95 1.95 1.95 1.95
EBIT -3.5 -3.4 -6.1 -4.7 -4.7 -3.7 -3.4 -3.1 -2.9 -2.6
EBIT, % -18.63 -18.51 -48.38 -35.74 -36.91 -31.64 -31.64 -31.64 -31.64 -31.64
Total Cash 3.7 4.2 7.4 3.8 3.1 3.6 3.3 3.0 2.8 2.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 4.0 2.8 2.4 2.6 2.9
Account Receivables, % 20.98 15.06 19.06 19.38 22.76
Inventories 2.2 2.5 2.7 2.9 2.7 2.1 1.9 1.8 1.6 1.5
Inventories, % 11.58 13.58 21.09 21.53 21.35 17.83 17.83 17.83 17.83 17.83
Accounts Payable 2.1 1.8 1.6 .8 .6 1.0 1.0 .9 .8 .7
Accounts Payable, % 10.92 9.5 12.99 6.34 4.77 8.9 8.9 8.9 8.9 8.9
Capital Expenditure -.2 -.2 -.1 -.3 .0 -.1 -.1 -.1 -.1 -.1
Capital Expenditure, % -1.09 -0.96087 -1.08 -2.03 -0.13349 -1.06 -1.06 -1.06 -1.06 -1.06
Tax Rate, % 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9
EBITAT -3.7 -4.1 -5.7 -4.7 -4.5 -3.6 -3.3 -3.1 -2.8 -2.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -7.7 -3.5 -5.3 -5.8 -4.8 -1.8 -3.0 -2.7 -2.5 -2.3
WACC, % 8.83 8.83 8.74 8.82 8.77 8.79 8.79 8.79 8.79 8.79
PV UFCF
SUM PV UFCF -9.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -2
Terminal Value -34
Present Terminal Value -23
Enterprise Value -32
Net Debt -3
Equity Value -30
Diluted Shares Outstanding, MM 0
Equity Value Per Share -65.05

What You Will Get

  • Real Sonoma Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Sonoma Pharmaceuticals, Inc. (SNOA).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to (SNOA).
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Sonoma’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for (SNOA).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for (SNOA).

Key Features

  • Comprehensive Financial Data: Gain access to precise historical figures and future forecasts for Sonoma Pharmaceuticals, Inc. (SNOA).
  • Tailorable Forecast Parameters: Modify highlighted fields such as WACC, growth rates, and profit margins to suit your analysis.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: Utilize user-friendly charts and summaries to effectively present your valuation findings.
  • Designed for All Skill Levels: A straightforward, intuitive layout tailored for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file for Sonoma Pharmaceuticals, Inc. (SNOA).
  2. Step 2: Review Sonoma's pre-filled financial data and projections.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you modify your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for your investment strategies.

Why Choose This Calculator for Sonoma Pharmaceuticals, Inc. (SNOA)?

  • User-Friendly Interface: Crafted for both novices and seasoned professionals.
  • Customizable Inputs: Effortlessly adjust parameters to suit your financial analysis.
  • Real-Time Valuation Updates: Observe immediate changes to Sonoma Pharmaceuticals’ valuation as you tweak inputs.
  • Preloaded Financials: Comes equipped with Sonoma’s latest financial data for swift evaluations.
  • Relied Upon by Experts: A go-to tool for investors and analysts making strategic decisions.

Who Should Use This Product?

  • Investors: Evaluate Sonoma Pharmaceuticals' (SNOA) market position before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts for (SNOA).
  • Startup Founders: Gain insights into how biotechnology companies like Sonoma Pharmaceuticals are valued.
  • Consultants: Provide detailed valuation analysis and reports for clients interested in (SNOA).
  • Students and Educators: Utilize real-world examples from (SNOA) to enhance learning of valuation practices.

What the Template Contains

  • Pre-Filled Data: Contains Sonoma Pharmaceuticals' historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automated calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
  • Key Financial Ratios: Evaluate Sonoma Pharmaceuticals' profitability, efficiency, and financial leverage.
  • Customizable Inputs: Easily modify revenue growth, profit margins, and tax rates.
  • Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.

No products were found matching.